Amr K S, Bayoumi F S, Eissa E, Abu-Zekry M
Medical molecular genetics Department, National Research Centre, Cairo, Egypt.
Immunogenetics Department, National Research Centre, Cairo, Egypt; Microbiology and Immunology Department, MSA University, Egypt.
Eur Ann Allergy Clin Immunol. 2019 Jul;51(4):159-164. doi: 10.23822/EurAnnACI.1764-1489.90. Epub 2019 Apr 15.
Celiac disease is an enteropathy induced by ingestion of gluten triggering an immune response in genetically predisposed individuals. MiRNAs are small non-coding RNAs that have a role as regulators of gene expression at the post transcriptional level. The aim of this study is to evaluate the possibility of using circulating miRNAs as non-invasive biomarkers in pediatric patients with celiac disease. In addition, we examine the effect of a gluten-free diet on the expression of these miRNAs in serum of CD patients. The expression pattern of miR-21 and miR-31 was estimated in serum of 25 untreated CD patients (recently diagnosed), 25 treated CD patients (on gluten-free diet) and 20 healthy controls using qRT-PCR. Our results demonstrated the significant up-regulation of microRNA-21 in the untreated celiac patients in comparison with the treated group and healthy controls. Moreover, miR-31 expression was significantly under-expressed in the untreated celiac patients in comparison with the treated group and healthy controls. Furthermore, the results showed that miR-21 expression level was significantly positively correlated with the tTG IgA auto-antibodies. In conclusion, circulating miRNA-21 and miRNA-31 could serve as potential non-invasive biomarkers for pediatric CD patients.
乳糜泻是一种由摄入麸质引发的肠病,会在具有遗传易感性的个体中触发免疫反应。微小RNA(miRNA)是一类小的非编码RNA,在转录后水平上作为基因表达的调节因子发挥作用。本研究的目的是评估将循环miRNA用作小儿乳糜泻患者非侵入性生物标志物的可能性。此外,我们研究了无麸质饮食对乳糜泻患者血清中这些miRNA表达的影响。使用qRT-PCR对25例未经治疗的乳糜泻患者(最近诊断)、25例接受治疗的乳糜泻患者(采用无麸质饮食)和20例健康对照者血清中的miR-21和miR-31表达模式进行了评估。我们的结果表明,与治疗组和健康对照相比,未经治疗的乳糜泻患者中微小RNA-21显著上调。此外,与治疗组和健康对照相比,未经治疗的乳糜泻患者中miR-31表达显著下调。此外,结果显示miR-21表达水平与组织转谷氨酰胺酶IgA自身抗体显著正相关。总之,循环miRNA-21和miRNA-31可作为小儿乳糜泻患者潜在的非侵入性生物标志物。